Alzheimer disease and neuroinflammation

Journal of Neural Transmission, Supplement

Volumn , Issue 59, 2000, Pages 53-57

  McGeer, Patrick L ^a   McGeer, E G ^a   Yasojima, K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD11B ANTIGEN; CD59 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C1S INHIBITOR; HLA DR ANTIGEN; MESSENGER RNA; AUTACOID; BIOLOGICAL MARKER; COMPLEMENT INHIBITOR;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; INFLAMMATION; MICROGLIA; NERVE INJURY; OSTEOARTHRITIS; PRIORITY JOURNAL; BRAIN; GENETICS; MACROPHAGE; METABOLISM; PHYSIOLOGY; UPREGULATION;

ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; C-REACTIVE PROTEIN; COMPLEMENT INACTIVATOR PROTEINS; HLA-DR ANTIGENS; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGE-1 ANTIGEN; MACROPHAGES; MICROGLIA; RNA, MESSENGER; UP-REGULATION;

EID: 0033624407     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6781-6_8     Document Type: Article

References (12)

1. Akiyama H, McGeer PL (1990) Brain microglia constitutively express β-2 integrins. J Neuroimmunol 30: 81-93
2. Jiang H, Robey FA, Gewurz H (1992) Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain. J Exp Med 175: 1373-1379
3. McGeer EG, McGeer PL (1998) The future use of complement inhibitors for the treatment of neurological diseases. Drugs 55: 739-746
4. McGeer EG, McGeer PL (1999) Brain inflammation in Alzheimer disease and the therapeutic implications. Curr Pharmacol Design 5: 821-826
5. McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21: 195-218
6. McGeer PL, Itagaki S, Tago H, McGeer EG (1987) Reactive microglia in patients with Fsenile dementia of the Alzheimer type are positive for the histocompatability glycoprotein HLA-DR. Neurosci Lett 79: 195-200
7. McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and antiinflammatory agents as negative risk factors for Alzheimer disease: A review of seventeen epidemiological studies. Neurology 47: 425-432
8. Rogers J, Luber-Narod J, Styren SD, Civin WH (1988) Expression of immune system-associated antigen by cells of the human central nervous system. Relationship to the pathology of Alzheimer disease. Neurobiol Aging 9: 339-349
9. Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P, Kogan F (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43: 1609-1611
10. Webster S, Lue L-F, Brachova L, Tenner AJ, McGeer PL, Terai K, Walker DG, Bradt B, Cooper NR, Rogers J (1997) Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol Aging 18: 415-421
11. Yasojima K, McGeer EG, McGeer PL (1999a) Complement regulators Cl inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease. Brain Res 833: 297-301
12. Yasojima K, Schwab C, McGeer EG, McGeer PL (1999b) Upregulated production and activation of the complement system in Alzheimer disease brain. Am J Pathol 154: 927-936